NCT07011706: ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis
- State
- Under way
- Phase
- Phase 2
- People
- 110 taking part
- Started
- 30 May 2025
- Primary completion
- 21 Sep 2026
- Arms
- ATI-045 group
- Results
- None posted
- 30 May 2025: Trial started
- 10 Jun 2025: Trial registered